Oncology is a big investment target – here’s what investors care about
Me-too drugs and ill-defined AI are less interesting than unmet need and AI with supporting evidence.
Pharma is making inroads into digital health, albeit slowly
Panelists highlight Roche's acquisition of Flatiron Health in February and use of AI/ML in drug development.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
US slower than Europe, emerging markets in liquid biopsy adoption
Blood-based cancer tests have market, but more evidence may be needed to verify validity and utility.
How oncology is adapting to the rise of artificial intelligence
Panel at MedCity CONVERGE discussed the practical applications of AI in the treatment of cancers.
Healthcare startups, this is your time (MedCity CONVERGE)
We are looking for a select group of digital health startups to attend and present.